Health ❯Patient Care
Genetic Disorders Clinical Research Neurological Disorders Genetics Clinical Outcomes Experimental Drugs Neurology Experimental Treatments Clinical Trials Treatment Outcomes
Ulefnersen, targeting FUS gene mutations, demonstrates safety, biomarker reduction, and functional recovery in early clinical use, with a global trial underway.
